Israeli Legal Opinion
Sydney, Jan 20, 2015 AEST (ABN Newswire) - Phytotech Medical Limited (
ASX:PYL) Israeli Legal Opinion - Medical Cannabis - Activities in Israel
1. Phytotech Medical Limited ACN 601 236 417, a company incorporated under the laws of the Commonwealth of Australia (the "Company"), has requested that we present an opinion as to whether activities concerning the development of delivery devices intended for administration of medical cannabis to patients, the financing of research regarding the development of said devices and the financing of research regarding medical applications of cannabis (collectively, the "Activities") can be legally conducted in the State of Israel under the Applicable Regulations, as such term is defined herein.
2. In connection with our opinions expressed herein, we have reviewed the following laws and regulations in Israel governing the use of cannabis for medicinal purposes in the State of Israel ("Applicable Regulations"):
(a) The Dangerous Drugs Ordinance [New Version], 5733 - 1973 (the "Ordinance") which, inter alia, mandates which substances are considered to be dangerous drugs, sets forth restrictions on the possession, use and application of any such substances and regulates the approved application and use of any such substances. The Ordinance authorizes the Director-General of the Ministry of Health (or any other official authorized by the Director-General with regard to the matter in question) to allocate permits for the import, export, diversion, manufacture, possession, preparation and use of dangerous drugs and drug delivery devices for dangerous drugs. The Ordinance defines cannabis as such a dangerous drug.
(b) Government decisions 3609, dated August 7, 2011, and 1050, dated December 15, 2013 under which the use of cannabis for medicinal purposes in the State of Israel is permitted, in accordance with the terms and conditions of said government decisions. As prescribed under the said government decisions, the Ministry of Health ("MOH") established the Israeli Medical Cannabis Agency (IMCA), a unit within the MOH responsible for the implementation of the Government and MOH decisions regarding all aspects of arrangements for the purchase, supply, instructions, approvals and information as regards the use of medical cannabis.
To view the full Israeli Legal Opinion, please visit:
http://media.abnnewswire.net/media/en/docs/ASX-PYL-706816.pdf
About MMJ Group Holdings Ltd
![Phytotech Medical ASX:PYL](https://abnnewswire.net/images/logos/37064en.jpg)
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/
Related Companies
Social Media
Share this Article